Encouraging Public Access to Pharmaceuticals Through Modified Protection of Clinical Trial Data

Authors

Scott M. Nolan II, Indiana University Maurer School of LawFollow

Document Type

Note

Publication Date

Summer 2023

Publication Citation

12 IP Theory 87

Abstract

Part I of this Article investigates the development of pharmaceuticals and clinical trial data with a focus on patent and data protection. Part II evaluates the effects of protection and the challenges it poses to widespread public pharmaceutical access. Part III discusses two scholarly approaches to the public access issue that focus on clinical data protection and their associated challenges. In light of these scholarly works, Part IV suggests a new approach to clinical trial data protection that aims to improve public pharmaceutical access while maintaining the incentives to invent for drug developers.

Recommended Citation

Nolan, Scott M. II (2023) "Encouraging Public Access to Pharmaceuticals Through Modified Protection of Clinical Trial Data," IP Theory: Vol. 12: Iss. 3, Article 3.
Available at: https://www.repository.law.indiana.edu/ipt/vol12/iss3/3